Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies.

Théophile H, Dutertre JP, Gérardin M, Valnet-Rabier MB, Bidault I, Guy C, Haramburu F, Hillaire-Buys D, Méglio C, Arimone Y.

Therapie. 2015 Sep-Oct;70(5):465-76. doi: 10.2515/therapie/2015028. Epub 2015 Jun 26.

PMID:
26423144
2.

Drugs and Sleep Apneas? A review of the French Pharmacovigilance database.

Linselle M, Montastruc F, Jantzen H, Valnet-Rabier MB, Haramburu F, Coquerel A, Gouraud A, Perault-Pochat MC, Bagheri H, Montastruc JL.

Therapie. 2015 Jul-Aug;70(4):347-50. doi: 10.2515/therapie/2014218. Epub 2015 Feb 16.

PMID:
25679185
3.

Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.

Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, Noize P, Haramburu F; EMIR Study Group on behalf of the French network of pharmacovigilance centres..

Fundam Clin Pharmacol. 2015 Feb;29(1):106-11. doi: 10.1111/fcp.12088. Epub 2014 Sep 25.

PMID:
24990220
4.

Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis.

Reitter M, Petitpain N, Latarche C, Cottin J, Massy N, Demoly P, Gillet P, Mertes PM; French Network of Regional Pharmacovigilance Centres..

Allergy. 2014 Jul;69(7):954-9. doi: 10.1111/all.12426. Epub 2014 May 10.

5.

Potential role of oxidative DNA damage in the impact of PNPLA3 variant (rs 738409 C>G) in hepatocellular carcinoma risk.

Limagne E, Cottet V, Cotte AK, Hamza S, Hillon P, Latruffe N, Delmas D; CiRCE Study Group..

Hepatology. 2014 Sep;60(3):1110-1. doi: 10.1002/hep.27004. Epub 2014 Jul 28. No abstract available.

PMID:
24425147
6.

Acute pancreatitis occurring after pamidronate infusions in two patients with spondyloarthritis.

Toussirot E, Vuitton L, Koch S, Valnet-Rabier MB.

Case Rep Rheumatol. 2013;2013:912692. doi: 10.1155/2013/912692. Epub 2013 Jun 13.

7.

Updating the French method for the causality assessment of adverse drug reactions.

Arimone Y, Bidault I, Dutertre JP, Gérardin M, Guy C, Haramburu F, Hillaire-Buys D, Meglio C, Penfornis C, Théophile H, Valnet-Rabier MB; Cercle de Réflexion sur l’Imputabilité (CRI)..

Therapie. 2013 Mar-Apr;68(2):69-76. doi: 10.2515/therapie/2013016. Epub 2013 Jun 18. Review.

PMID:
23773347
8.

[Safety update on vaccination during pregnancy].

Moltenis M, Valnet-Rabier MB, Leroy J, Kantelip JP.

Therapie. 2012 Sep-Oct;67(5):457-63. doi: 10.2515/therapie/2012055. Epub 2012 Dec 18. Review. French.

PMID:
23241255
9.

First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.

Durrieu G, Palmaro A, Pourcel L, Caillet C, Faucher A, Jacquet A, Ouaret S, Perault-Pochat MC, Kreft-Jais C, Castot A, Lapeyre-Mestre M, Montastruc JL; French Network of Pharmacovigilance Centres..

Drug Saf. 2012 Oct 1;35(10):845-54. doi: 10.2165/11631800-000000000-00000.

PMID:
22967189
10.

[Pharmacovigilance study of influenza A H1N1 vaccination during the 2009-2010 season in France].

Montastruc JL; Rèseau Français des Centres Régionaux de Pharmacovigilance..

Bull Acad Natl Med. 2011 Jun;195(6):1309-16; discussion 1316-7. French.

PMID:
22530521
11.

[National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance].

Durrieu G, Caillet C, Lacroix I, Jacquet A, Faucher A, Ouaret S, Sommet A, Perault-Pochat MC, Kreft-Jaïs C, Castot A, Damase-Michel C, Montastruc JL; le réseau français des centres de pharmacovigilance..

Therapie. 2011 Nov-Dec;66(6):527-40. doi: 10.2515/therapie/2011075. Epub 2011 Dec 21. Review. French.

PMID:
22186078
12.

[Update of the French drug reaction assessment method].

Cercle de Reflexion sur l'Imputabilite., Arimone Y, Bidault I, Dutertre JP, Gérardin M, Guy C, Haramburu F, Hillaire-Buys D, Meglio C, Penfornis C, Théophile H, Valnet-Rabier MB.

Therapie. 2011 Nov-Dec;66(6):517-25. Epub 2011 Dec 21. Review. French.

PMID:
22186077
13.

Réactualisation de la méthode française d'imputabilité des effets indésirables des médicaments.

Cercle de Réflexion sur l’Imputabilité (CRI)., Arimone Y, Bidault I, Dutertre JP, Gérardin M, Guy C, Haramburu F, Hillaire-Buys D, Meglio C, Penfornis C, Théophile H, Valnet-Rabier MB.

Therapie. 2011 Nov-Dec;66(6):517-25. doi: 10.2515/therapie/2011073. French.

PMID:
27393472
14.

Pioglitazone-induced progressive pancytopenia.

Favre G, Valnet-Rabier MB, Brousse A, Lepiller Q, Kantelip JP.

Ann Pharmacother. 2011 Jan;45(1):131-3. doi: 10.1345/aph.1P497. Epub 2011 Jan 4. No abstract available.

PMID:
21205948
15.

Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France.

Caillet C, Durrieu G, Jacquet A, Faucher A, Ouaret S, Perrault-Pochat MC, Kreft-Jaïs C, Castot A, Montastruc JL; French Network of Pharmacovigilance Centres..

Eur J Clin Pharmacol. 2011 Jun;67(6):649-51. doi: 10.1007/s00228-010-0961-8. Epub 2010 Dec 14. No abstract available.

PMID:
21153631
16.

[Drugs and heat wave: SIRIUS, a multicentric case-control study in patients older than 65 years during 2007 summer in France].

Sommet A, Shams R, Valnet-Rabier MB, Jean-Pastor MJ, Castot A, Lapeyre-Mestre M, Montastruc JL.

Therapie. 2009 Sep-Oct;64(5):295-301. doi: 10.2515/therapie/2009044. Epub 2009 Oct 30. French.

PMID:
19863904
17.

c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome.

Valnet-Rabier MB, Challier B, Thiebault S, Angonin R, Margueritte G, Mougin C, Kantelip B, Deconinck E, Cahn JY, Fest T.

Br J Haematol. 2005 Mar;128(6):767-73.

PMID:
15755279
18.

Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large B cell lymphoma: a preferential survivin-cyclin B link.

Kuttler F, Valnet-Rabier MB, Angonin R, Ferrand C, Deconinck E, Mougin C, Cahn JY, Fest T.

Leukemia. 2002 Apr;16(4):726-35.

19.

[Pharmacology. The proper use of drugs. 10/12. The preparation and administration of antineoplastic agents and adjuvants].

Valnet-Rabier MB, Limat S, Woronoff-Lemsi MC, Belon JP.

Soins. 2000 Mar;(643):51-2. French. No abstract available.

PMID:
11075232

Supplemental Content

Loading ...
Support Center